Aurobindo gets FDA approval for chlordiazepoxide hydrochloride and clidinium bromide capsules
EAST WINDSOR, N.J. – Aurobindo Pharma Limited has received final approval from U.S. Food and Drug Administration for its Abbreviated New Drug Application chlordiazepoxide hydrochloride and clidinium bromide capsules 5mg/2.5mg.